Andrew J Sinnamon
Overview
Explore the profile of Andrew J Sinnamon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
583
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Serenari M, Berti D, Rivera B, Newhook T, Kristjanpoller W, Ruzzenente A, et al.
Ann Surg Oncol
. 2025 Mar;
PMID: 40050485
Background: Gallbladder cancer (GBC) has a poor prognosis, particularly in advanced stages, with surgery often offering limited survival benefit. This study aimed to identify risk factors for futile surgery (FS),...
2.
Lin Y, Pimiento J, Milano J, Riccardi D, Mckinnie N, Hume E, et al.
Contemp Clin Trials Commun
. 2025 Jan;
43():101421.
PMID: 39810840
Introduction: Individuals with esophageal and gastroesophageal junction (GEJ) cancers are at especially high risk of malnutrition. However, most patients with malnutrition do not receive adequate nutritional support. We conducted a...
3.
Bryant J, Nakashima J, Khatri V, Sinnamon A, Denbo J, Hodul P, et al.
J Clin Med
. 2024 Nov;
13(22).
PMID: 39597944
Background/objectives: Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers. Surgical resection is the most reliable chance for cure, but high rates of positive margins and local failure persist....
4.
Shannon A, Mehta R, Mok S, Lauwers G, Baldonado J, Fontaine J, et al.
Ann Surg Oncol
. 2024 Oct;
32(1):581-582.
PMID: 39412693
No abstract available.
5.
Shannon A, Mehta R, Mok S, Lauwers G, Baldonado J, Fontaine J, et al.
Ann Surg Oncol
. 2024 Aug;
31(13):8616-8626.
PMID: 39154152
Background: Mismatch repair deficient (dMMR) gastroesophageal cancers (GEC) are a distinct subgroup. Among patients with locally advanced disease, previous trial data suggest a good response to neoadjuvant immune checkpoint inhibitors...
6.
Shannon A, Sinnamon A
Ann Surg Oncol
. 2024 Aug;
31(13):8680-8681.
PMID: 39150622
No abstract available.
7.
Saeed S, Sinnamon A, Fontaine J, Mehta R, Pena L, Mok S, et al.
Surg Endosc
. 2024 Aug;
38(10):6046-6052.
PMID: 39134721
Background: Delayed gastric emptying (DGE) is a common complication after esophagectomy. BOTOX injections and pyloric surgeries (PS), including pyloroplasty (PP) and pyloromyotomy (PM), are performed intraoperatively as prophylaxis against DGE....
8.
Drake J, Sinnamon A, Saeed S, Mehta R, Palm R, Baldonado J, et al.
J Gastrointest Oncol
. 2024 May;
15(2):544-554.
PMID: 38756649
Background: Surgical resection of esophageal and gastroesophageal junction cancers is a very complex procedure with step learning curve. New technologies have made minimally invasive surgery possible, but challenges still remain...
9.
Sinnamon A, Mehta R, Saeed S, Lauwers G, Palm R, Frakes J, et al.
Cancers (Basel)
. 2023 Sep;
15(17).
PMID: 37686650
Neoadjuvant chemoradiation with esophagectomy is standard management for locally advanced esophageal adenocarcinoma. Induction chemotherapy with a tailored approach to chemoradiation based on metabolic response to therapy on PET was explored...
10.
Sharon C, Tortorello G, Ma K, Sinnamon A, Mitchell T, Karakousis G, et al.
Ann Surg Oncol
. 2023 Jun;
30(9):5329-5332.
PMID: 37332026
No abstract available.